Omalizumab in Chronic Inducible Urticaria: a Real-Life Study of Efficacy, Safety, Predictors of Treatment Outcome, Time to Response and Relapse

被引：0
|
作者：
Yu, Miao [1 ]
Maurer, Marcus [2 ]
Chen, Yudi [3 ]
Zhao, Zuotao [1 ]
机构：
[1] Peking Univ, Beijing, Peoples R China
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Beijing Hosp, Beijing, Peoples R China
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
083
引用
收藏
页码：AB26 / AB26
页数：1
相关论文
共 50 条
  • [31] Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety
    Kahveci, M.
    Soyer, O.
    Buyuktiryaki, B.
    Sekerel, B. E.
    Sahiner, U. M.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2020, 48 (04) : 368 - 373
  • [32] Omalizumab treatment in children with chronic spontaneous urticaria: Efficacy and safety
    Kahveci, M.
    Sahiner, U. M.
    Buyuktiryaki, B.
    Sekerel, B. E.
    Soyer, O.
    ALLERGY, 2019, 74 : 867 - 868
  • [33] Omalizumab in chronic spontaneous urticaria treatment: Real life experiences
    Engin, Burhan
    Celik, Ugur
    Birben, Aslihan Ozge
    Askin, Ozge
    Kutlubay, Zekayi
    Serdaroglu, Server
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2019, 53 (04): : 145 - 149
  • [34] Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes
    Dursun, A. B.
    Karakis, Pasaoglu G.
    Ayhan, V
    ALLERGY, 2016, 71 : 187 - 187
  • [35] Can the response to Omalizumab be influenced by treatment duration? A real-life study
    Sposato, Bruno
    Scalese, Marco
    Latorre, Manuela
    Novelli, Federica
    Scichilone, Nicola
    Milanese, Manlio
    Olivieri, Carmela
    Perrella, Antonio
    Paggiaro, Pierluigi
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 44 : 38 - 45
  • [36] Chronic urticaria in children: a real-life study
    Brandao, Larissa
    Araujo, Chayanne
    Moura, Ana Carla
    Bruscky, Dayanne
    Dela Bianca, Ana Caroline
    Camelo-Nunes, Ines
    Ensina, Luis Felipe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB25 - AB25
  • [37] Omalizumab in chronic urticaria; real-life data of 6-year-experience
    Ozdemir, Adem
    Bilgic, Asli
    Koyuncu, Mehmet Ali
    Yilmaz, Ertan
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2021, 15 (03): : 66 - 73
  • [38] Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
    Vadasz, Zahava
    Tal, Yuval
    Rotem, Menachem
    Shichter-Confino, Vered
    Mahlab-Guri, Keren
    Graif, Yael
    Kessel, Aharon
    Agmon-Levin, Nancy
    Maoz-Segal, Ramit
    Kivity, Shmuel
    Benor, Shira
    Lachover-Roth, Idit
    Zeldin, Yuri
    Stein, Migel
    Toker, Ori
    Hassoun, Gamal
    Bezalel-Rosenberg, Shira
    Toubi, Elias
    Asher, Ilan
    Sthoeger, Zev
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1743 - 1745
  • [39] Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience
    Nettis, Eustachio
    Cegolon, Luca
    Di Leo, Elisabetta
    Canonica, Walter Giorgio
    Detoraki, Aikaterini
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (03) : 318 - 323
  • [40] "Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma
    Al-Ahmad, Mona
    Arifhodzic, Nermina
    Nurkic, Jasmina
    Maher, Ahmed
    Rodriguez-Bouza, Tito
    Al-Ahmed, Nasser
    Sadek, Ali
    Jusufovic, Edin
    MEDICAL PRINCIPLES AND PRACTICE, 2018, 27 (03) : 260 - 266
12345